Tositumomab and disease progression Patient Reports February 11, 2012
Tositumomab Side Effects Report #5307492-4
Tositumomab side effect was reported by a Physician from UNITED STATES on Apr 16, 2007. Male patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: disease progression, lung adenocarcinoma. Tositumomab dosage: 450MG SINGLE DOSE. During the same period patient was treated with IODINE I, IODINE I. Patient died on 12/14/2005.
Tositumomab Side Effects Report #5136276-5
Tositumomab side effect was reported by a Physician from UNITED STATES on June 06, 2005. Male patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: disease progression, lung adenocarcinoma. Tositumomab dosage: 450MG SINGLE DOSE. During the same period patient was treated with IODINE I, IODINE I. Patient recovered.
Tositumomab Side Effects Report #5165648-8
Tositumomab side effect was reported by a Physician from UNITED KINGDOM on July 02, 1996. Female patient, 60 years of age, weighting 123.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: contusion, disease progression, lower respiratory tract infection, lung consolidation, pelvic venous thrombosis, platelet count decreased, pleural effusion, pleuritic pain, pulmonary embolism
. Tositumomab dosage: unknown. During the same period patient was treated with IODINE I, IODINE I. Patient was hospitalized. Patient recovered.Tositumomab Side Effects Report #4760304-X
Tositumomab side effect was reported by a Physician from CANADA on Aug 22, 2005. Female patient, 58 years of age, was diagnosed with b-cell lymphoma, deep vein thrombosis
, oedema peripheral, prophylaxis, seasonal allergy and was treated with Tositumomab. After drug was administered, patient experienced the following side effects: disease progression, respiratory failure. Tositumomab dosage: 450MG SINGLE DOSE. During the same period patient was treated with IODINE I, IODINE I, COUMADIN, LASIX, SPIRONOLACTONE, BACTRIM DS, REACTINE. Patient died on 07/21/2005.
Tositumomab and disease progression 